Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HES
HES
GSK's asthma drug Nucala gets speedy review for rare blood disorder
Endpoints
Wed, 05/27/20 - 10:25 am
GSK
FDA
Nucala
hypereosinophilic syndrome
HES
priority review
Nucala works in rare inflammatory disease, says GSK
PM Live
Wed, 11/13/19 - 09:55 am
GSK
clinical trials
Nucala
hypereosinophilic syndromes
HES
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
Endpoints
Thu, 04/4/19 - 10:30 am
AstraZeneca
Fasenra
asthma
HES
FDA